The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 25, 2023

Filed:

Mar. 31, 2020
Applicant:

Array Biopharma Inc., Boulder, CO (US);

Inventors:

James F. Blake, Longmont, CO (US);

Mark Laurence Boys, Boulder, CO (US);

Mark Joseph Chicarelli, Longmont, CO (US);

Adam W. Cook, Broomfield, CO (US);

Mohamed S. A. Elsayed, Boulder, CO (US);

Jay Bradford Fell, Longmont, CO (US);

John P. Fischer, Longmont, CO (US);

Ronald Jay Hinklin, Longmont, CO (US);

Yutong Jiang, Longmont, CO (US);

Oren T. McNulty, Nederland, CO (US);

Macedonio J. Mejia, Denver, CO (US);

Martha E. Rodriguez, Lafayette, CO (US);

Christina E. Wong, Boulder, CO (US);

Assignee:

Array BioPharma Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 253/06 (2006.01); A61K 31/53 (2006.01); C07D 471/04 (2006.01); A61P 35/00 (2006.01); C07D 401/14 (2006.01); C07D 471/10 (2006.01); C07D 513/10 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61P 35/00 (2018.01); C07D 401/14 (2013.01); C07D 471/10 (2013.01); C07D 513/10 (2013.01); A61K 45/06 (2013.01);
Abstract

Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.


Find Patent Forward Citations

Loading…